Do SDOH Drive Survival Outcomes With Brexu-Cel in ALL?
Written by
American Journal Managed Care
Published
0
comments
0
min
Race, ethnicity, and social factors can influence survival outcomes in adults with relapsed or refractory B-cell acute lymphoblastic leukemia (B-ALL) receiving brexucabtagene autoleucel (brexu-cel).